Influenza Vaccines - Immunology
Research News and Information

Sunday, November 22, 2009

Update on influenza A (H1N1) 2009 monovalent vaccines.

7 Oct 2009 On September 15, 2009, four influenza vaccine manufacturers received approval from the Food and Drug Administration for use of influenza A (H1N1) 2009 monovalent influenza vaccines in the prevention of influenza caused by the 2009 pandemic influenza ... Read more...

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

29 Sep 2009 Novel strategies are required to provide rapid vaccine coverage in the event of an influenza pandemic. A phase I/II dose finding/formulation study was performed with a whole-virus H5N1 clade 1 A/Vietnam vaccine (2-dose priming regimen) to evaluate ... Read more...

Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review.

29 Sep 2009 Cardiac complications of influenza infection, such as myocarditis, are well recognised, but the role of influenza as a trigger of acute myocardial infarction is less clear. We did a systematic review of the evidence that influenza (including ... Read more...

Latest indexed articles for 'Influenza Vaccines - Immunology'

These are the very latest articles for this heading:

• Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines. 7 Oct 2009
• Recommended composition of influenza virus vaccines for use in the 2010 influenza season (southern hemisphere winter). 7 Oct 2009
• Update on influenza A (H1N1) 2009 monovalent vaccines. 7 Oct 2009
• How to win trust over flu. 6 Oct 2009
• Public health. Rethinking influenza. 30 Sep 2009
• AVMA updates backgrounder on canine influenza. 29 Sep 2009
• A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses. 29 Sep 2009
• Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. 29 Sep 2009
• Comparative efficacy of inactivated and live attenuated influenza vaccines. 22 Sep 2009
• Swine flu outbreak. China first to vaccinate against novel H1N1 virus. 16 Sep 2009
• Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity. 13 Sep 2009
• Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. 13 Sep 2009
• A swine of a pandemic. 30 Aug 2009
• Influenza and autoimmunity. 30 Aug 2009
• Prospects for developing an effective particle-mediated DNA vaccine against influenza. 30 Aug 2009
• Mark Mulligan leads Emory swine flu vaccine trial. Interview by Brooke Grindlinger. 30 Aug 2009
• Pandemic vaccine enters clinical trials. 30 Aug 2009
• The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. 30 Aug 2009
• China boosts pandemic surveillance. 25 Aug 2009
• [New influenza. What you should know about vaccination (interview by Dr. Judith Neumaier)] 18 Aug 2009

See a longer list of these articles.

Technical information about 'Influenza Vaccines'

Definition: Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed or attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The vaccine is usually bivalent or trivalent, containing one or two INFLUENZAVIRUS A strains and one INFLUENZAVIRUS B strain.

Registry Number: 0

Descriptor UI: D007252

Alternative terms: Influenza Vaccines; Vaccines, Influenza; Influenzavirus Vaccines; Vaccines, Influenzavirus; Influenza Virus Vaccines; Vaccines, Influenza Virus; Virus Vaccines, Influenza; Flu Vaccines; Vaccines, Flu; Influenza Vaccine; Vaccine, Influenza; Trivalent Live Attenuated Influenza Vaccine; LAIV vaccine; vaccine, LAIV; FluMist; MedImmune Vaccines Brand of Trivalent Live Attenuated Influenza Vaccine; CAIV-T vaccine;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D20.215.894.899.302;

History Note: 2005 (1963)

Technical Notes: coordinate IM with specific influenza virus or virus subtype /immunol (IM); SCR records for several specific influenza vaccines are also available; not for Haemophilus influenzae vaccines ( = HAEMOPHILUS VACCINES)